Valuation: DarioHealth Corp.

Market Cap 75.02M 64.94M 60.7M 55.48M 105M 7.15B 106M 712M 279M 3.58B 282M 276M 11.92B P/E 2026 *
-1.94x
P/E 2027 * -3.94x
Enterprise Value 75.02M 64.94M 60.7M 55.48M 105M 7.15B 106M 712M 279M 3.58B 282M 276M 11.92B EV / Sales 2026 *
2.88x
EV / Sales 2027 * 2.01x
Free-Float
84.11%
Yield 2026 *
-
Yield 2027 * -
1 day+0.91%
1 week+12.95%
Current month+6.74%
1 month+15.82%
3 months-2.76%
6 months-29.45%
Current year-31.81%
1 week 6.7
Extreme 6.695
8.2
1 month 6.07
Extreme 6.07
8.2
Current year 5.84
Extreme 5.8445
13.64
1 year 5.84
Extreme 5.8445
17.74
3 years 5.84
Extreme 5.8445
69.8
5 years 5.84
Extreme 5.8445
387.8
10 years 5.84
Extreme 5.8445
1,880
Manager TitleAgeSince
Corporate Officer/Principal - 11/08/2011
Chief Executive Officer 52 09/08/2013
Director of Finance/CFO 38 01/01/2021
Director TitleAgeSince
Chairman 52 23/11/2014
Director/Board Member 69 12/11/2013
Director/Board Member 57 23/11/2014
Date Insider Type Main position Quantity % Market Cap.
23/07/26 Buy

Director

14,430 0.1973%
11/09/25 Free

Director

20,000 0.0440%
11/09/25 Free

Director

20,000 0.0440%
Change 5-day change 1-year change 3-year change Capi.($)
+0.85%+12.95%-22.86%-87.72% 75.02M
+1.32%+4.10%-16.42%+4.25% 188B
+1.03%+4.19%-3.16%+7.62% 114B
+1.66%+7.76%+13.54%+76.15% 62.02B
+2.38%+3.92%+35.52%+60.21% 55.26B
+0.40%+5.85%-6.45%-36.21% 48.93B
+1.45%+1.98%+13.89%-20.62% 33.08B
+0.35%-18.70% - - 29.66B
-0.43%+0.59%+45.97%-11.13% 24.78B
+8.53%+11.42%-5.85%+18.17% 23.91B
Average +1.81%+2,937.98%+6.02%+1.19% 58.01B
Weighted average by Cap. +1.55%+2,681.39%+0.90%+13.48%

Financials

2026 *2027 *
Net sales 26.01M 22.52M 21.05M 19.24M 36.25M 2.48B 36.82M 247M 96.86M 1.24B 97.68M 95.55M 4.13B 37.33M 32.32M 30.21M 27.61M 52.02M 3.56B 52.84M 354M 139M 1.78B 140M 137M 5.93B
Net income -30.3M -26.23M -24.52M -22.41M -42.23M -2.89B -42.89M -288M -113M -1.45B -114M -111M -4.82B -14.34M -12.42M -11.61M -10.61M -19.99M -1.37B -20.3M -136M -53.41M -684M -53.86M -52.69M -2.28B
Net Debt - -
Logo DarioHealth Corp.
DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
Employees
163
Date Price Change Volume
11/08/26 $7.725 +0.85% 37,382
10/08/26 $7.660 +4.93% 24,337
07/08/26 $7.300 -5.78% 29,574
06/08/26 $7.748 +1.15% 3,964
05/08/26 $7.660 +11.50% 17,082
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
7.660USD
Average target price
15.25USD
Spread / Average Target
+99.09%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DRIO Stock